This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Center JR et al. (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297: 387–394
Center JR et al. (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353: 878–882
Kaufman JM et al. (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 16: 510–516
Lyles KW et al. (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357: 1799–1809
Nguyen ND et al. (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18: 1109–1117
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Dr Eisman has participated in multicenter international studies, received research funding and/or served as a consultant for Amgen (consultant, advisory board, study investigator), deCode Genetics (consultant), Eli Lilly (consultant, advisory board, study investigator), GE Lunar (consultant), Merck, Sharp and Dohme (consultant, advisory board), Novartis (consultant, advisory board, study investigator), NPS Pharmaceuticals (consultant), Organon (consultant, study investigator), Roche-GSK (consultant, advisory board, study investigator), Sanofi-Aventis (consultant, advisory board), Servier (consultant, advisory board), and Wyeth Australia (consultant).
Rights and permissions
About this article
Cite this article
Eisman, J. Osteoporosis prevention and treatment in elderly men—a cost-effective strategy. Nat Rev Endocrinol 4, 198–199 (2008). https://doi.org/10.1038/ncpendmet0753
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0753